Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9 Pt 2
|
pubmed:dateCreated |
1987-12-10
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0040-4470
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
17-23
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:3672402-Combined Modality Therapy,
pubmed-meshheading:3672402-Humans,
pubmed-meshheading:3672402-Male,
pubmed-meshheading:3672402-Prostatic Neoplasms,
pubmed-meshheading:3672402-Testicular Neoplasms,
pubmed-meshheading:3672402-Texas,
pubmed-meshheading:3672402-Urinary Bladder Neoplasms
|
pubmed:year |
1987
|
pubmed:articleTitle |
Urologic cancer. Urologic Oncology Workgroup, Legislative Task Force on Cancer in Texas.
|
pubmed:publicationType |
Journal Article
|